The article “A Promising Tool in Retina Regeneration: Current Perspectives and Challenges When Using Mesenchymal Progenitor Stem Cells in Veterinary and Human Ophthalmological Applications” discusses the potential of MSCs in treating retinal diseases like age-related macular degeneration, glaucoma, and diabetic retinopathy. MSCs are highlighted for their regenerative properties, including immunomodulation and secretion of growth factors. Animal studies show promising results for retinal regeneration, but clinical applications face challenges that require further research.